| Date Filed | Type | Description |
| 10/12/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2023 |
4
| CARLSON CAPITAL L P (10% Owner) has filed a Form 4 on Glatfelter Corp|
Txns:
| Bought 250,000 shares
@ $1.9537, valued at
$488.4k
Bought 75,000 shares
@ $1.9, valued at
$142.5k
|
|
| 08/17/2023 |
4
| CARLSON CAPITAL L P (10% Owner) has filed a Form 4 on Glatfelter Corp|
Txns:
| Bought 180,000 shares
@ $2, valued at
$360k
Bought 5,000 shares
@ $2.0258, valued at
$10.1k
Bought 65,000 shares
@ $1.9993, valued at
$130k
|
|
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/10/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/12/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/31/2023 |
SC 13D/A
| CARLSON CAPITAL L P reports a 13.2% stake in Glatfelter Corporation |
| 03/31/2023 |
4
| CARLSON CAPITAL L P (10% Owner) has filed a Form 4 on Glatfelter Corp|
Txns:
| Bought 500,000 shares
@ $3.0938, valued at
$1.5M
Exercised (in-or-at-the-money) 50,000 options to buy
@ $2.5, valued at
$125k
|
|
| 02/24/2023 |
SC 13G
| CARLSON CAPITAL L P reports a 5.2% stake in Albireo Pharma, Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/09/2023 |
SC 13G/A
| CARLSON CAPITAL L P reports a 4.3% stake in Exicure, Inc. |
| 02/09/2023 |
SC 13G/A
| CARLSON CAPITAL L P reports a 5.1% stake in TFF Pharmaceuticals, Inc. |
| 12/06/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/28/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/21/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/17/2022 |
SC 13D
| CARLSON CAPITAL L P reports a 12.1% stake in Glatfelter Corporation |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/11/2022 |
SC 13G
| CARLSON CAPITAL L P reports a 7.1% stake in Zogenix, Inc. |
| 02/25/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| CARLSON CAPITAL L P reports a 0% stake in Exit Filing)* MoneyGram International, Inc. |
| 02/11/2022 |
SC 13G/A
| CARLSON CAPITAL L P reports a 0% stake in Exit Filing)* Cosan Ltd. |
| 02/11/2022 |
SC 13G/A
| CARLSON CAPITAL L P reports a 4.9% stake in Exit Filing )* Glatfelter Corporation |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/10/2022 |
SC 13D/A
| CARLSON CAPITAL L P reports a 71% stake in SWK HOLDINGS CORPORATION |
| 12/28/2021 |
SC 13D/A
| CARLSON CAPITAL L P reports a 71% stake in SWK HOLDINGS CORPORATION |
| 11/23/2021 |
SC 13D/A
| CARLSON CAPITAL L P reports a 71% stake in SWK HOLDINGS CORPORATION |
| 11/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/12/2021 |
SC 13D/A
| CARLSON CAPITAL L P reports a 71.1% stake in SWK HOLDINGS CORPORATION |
| 09/17/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|